MT Petrucci
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions
- Chemokine receptors and signaling
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 14
- Acute Myeloid Leukemia Research 1
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Chemokine receptors and signaling 2
- Co-authors
- J Woodliff (2 shared papers)Ryan J. A. Chang (2 shared papers)Joshua Epstein (2 shared papers)Hong Xiao (2 shared papers)Hironobu Hata (2 shared papers)Meletios Α. Dimopoulos (5 shared papers)Martin Kropff (5 shared papers)Roman Hájek (2 shared papers)
- Journals
- Blood (3 papers)Haematologica (2 papers)Journal of Clinical Oncology (2 papers)HemaSphere (2 papers)Cancer Treatment Reviews (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
MT Petrucci
13 papers receiving 296 citations
Peers
Comparison fields: 5 of 32
- Hematology 235
- Oncology 130
- Genetics 32
- Immunology and Allergy 17
- Immunology 46
Countries citing papers authored by MT Petrucci
This map shows the geographic impact of MT Petrucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MT Petrucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MT Petrucci more than expected).
Fields of papers citing papers by MT Petrucci
This network shows the impact of papers produced by MT Petrucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MT Petrucci. The network helps show where MT Petrucci may publish in the future.
Co-authors
The 25 scholars most cited alongside MT Petrucci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 120 | |
| 2 | 2012 | 48 | |
| 3 | 1988 | 28 | |
| 4 | 1996 | 27 | |
| 5 | 2011 | 22 | |
| 6 | 2006 | 15 | |
| 7 | Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients. | 2000 | 14 |
| 8 | Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm) | 2008 | 7 |
| 9 | 2021 | 7 | |
| 10 | 1993 | 6 | |
| 11 | 2019 | 2 | |
| 12 | 2009 | 2 | |
| 13 | 2009 | 1 | |
| 14 | 2023 | 0 | |
| 15 | Report of the European Myeloma Network (EMN) workshop on multiparametric flow cytometry in multiple myeloma and related disorders | 2007 | 0 |
About MT Petrucci
MT Petrucci is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Immunology, having authored 15 papers that have together received 299 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (3 papers), Glycosylation and Glycoproteins Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chemokine receptors and signaling (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and Multiple and Secondary Primary Cancers (1 paper). The work is most often cited by research in Hematology (235 citations), Oncology (130 citations), Genetics (32 citations), Immunology and Allergy (17 citations) and Immunology (46 citations). MT Petrucci has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include J Woodliff, Ryan J. A. Chang, Joshua Epstein, Hong Xiao, Hironobu Hata, Meletios Α. Dimopoulos, Martin Kropff, Roman Hájek, Annabel Nixon and Michel Delforge. Their work appears in journals such as Blood, Haematologica, Journal of Clinical Oncology, HemaSphere and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.